The results come as Dexcom is awaiting a decision from the Centers for Medicare and Medicaid Services to expand Medicare ...
DexCom, Inc. (NASDAQ: DXCM), the global leader in glucose biosensing, today announced that results from the landmark CONNECT randomized controlled trial have been published in The New England Journal ...
DexCom (DXCM) stock jumps as peer-reviewed data from a study for the G7 insulin pump in type 2 diabetes boost its Medicare coverage hopes.
The FDA has approved San Diego, California-based Dexcom for a Bluetooth-enabled continuous glucose monitor (CGM), called the G5 Mobile CGM system. Correction: A previous version of this article ...
Dexcom is poised to share new data on the benefits of its continuous glucose monitoring technology (CGM), which the company says reinforces the need to broaden CGM access beyond insulin-treated ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. The Dexcom G7 15 Day ...
DexCom receives a BUY rating due to strong growth, expanding margins, and the launch of Stelo, the first OTC CGM for non-insulin users. DXCM raised its 2025 outlook, targeting $4.6B+ in revenue, 62% ...
– FriskaAi, an AI-powered healthcare platform, has announced an agreement with Dexcom, Inc., a global leader in glucose biosensing, to integrate data from Dexcom G7 and Dexcom G6 Continuous Glucose ...
Dexcom has received approval from the FDA for a new version of its smartphone connected Dexcom Share platform that will eliminate the docking cradle and allow a patient's continuous glucose monitor ...
Dexcom said it has received 56 reports of injuries, including seizures, loss of consciousness, vomiting and other symptoms related to hypoglycemia or hyperglycemia. The FDA listed the issue this week ...
MONTREAL--(BUSINESS WIRE)--Dexcom, Inc. (NASDAQ: DXCM), a global leader in glucose biosensing, applauds the Québec government for its recent decision to expand coverage of Dexcom Continuous Glucose ...
Barchart on MSN
Here's what to expect from DexCom’s next earnings report
DXCM is expected to release its Q3 2026 earnings after the market closes on Thursday, Oct. 29. Ahead of the event, analysts ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results